Revance(RVNC) - 2023 Q2 - Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Jessica Serra - Head, IR, Communications & ESG Mark Foley - CEO Dustin Sjuts - President Toby Schilke - CFO Conference Call Participants Seamus Fernandez - Guggenheim David Amsellem - Piper Sandler Chris Shibutani - Goldman Sachs Stacy Ku - TD Cowen Annabel Samimy - Stifel Tim Lugo - William Blair Terence Flynn - Morgan Stanley Navann Ty - BNP Charles Lee - Mizuho Douglas Tsao - H.C. Wain ...